Vision
Healing humanity one Biotech at a time.
Our vision is reducing the barrier to market entry for Biotechs while addressing the unmet needs in emerging Asia and Africa.
Mission
Serving Biotech by navigating their way.
Our mission is to achieve this vision by providing our Biotech partners with the highest quality, efficient, and accelerated clinical trials in emerging Asia and Africa, ultimately resulting in optimal returns on their investments.
This endeavor is propelled by our experienced clinical research team, leveraging local expertise, access to diverse populations, and forthcoming innovative digital solutions. Additionally, our clinical trial solutions are fortified by the implementation of registration, commercial, and local manufacturing strategies meticulously tailored to the specific needs of our Biotech partners
Our Team has
ISO 9001 Compliant Clinical Operations Globally.
Celero Global's ISO 9001 certification verifies our commitment to upholding the highest quality standards in our operations.
By integrating quality assurance requirements into our processes and activities, we ensure consistency, reliability, and compliance in international clinical research for all our clients.
Specializing in emerging markets, we offer deep local expertise to navigate unique challenges and opportunities.
Celero Pillars
High Quality
Accelerated Study Timelines
Diverse Patient Population
Commercial & Registration Strategies
Local Know-How
Synergistic Clinical Research Team
Celero Focus Countries
Delivering high-quality, accelerated, and cost-controlled clinical trial services in 29 countries with a focus on Emerging Asia & Africa in addition to the US, EU, and LATAM.
Leadership Team
Adham Rezk
CEO
Adham is a renowned serial entrepreneur, neuroscientist, and commercial expert with an exceptional 15-year track in running commercial and technology companies.
As a pioneer in the global commercialization of biological therapeutics, he has spearheaded successful initiatives across diverse markets including Africa, Asia, the Middle East and Africa (MEA), Latin America (LATAM), and North America.
Adham's deep scientific background and strong business acumen have allowed him to effectively bridge the gap between innovative products and successful commercial strategies.
His entrepreneurial spirit and visionary approach have enabled him to identify emerging market opportunities and drive the development and rollout of impactful solutions that have improved people's lives around the world. Adham's commercial expertise and transformative leadership have driven remarkable success, generating over $350 million in revenue.
Prior to starting his entrepreneurial career, he held senior positions at GlaxoSmithKline (GSK), where he leveraged his extensive knowledge and networks to accelerate the expansion of the company's portfolio in the MEA region.
Antoinette Quinsaat
COO
Former Head of Clinical Operations for the international region at GSK, Sanofi, and Novartis, with over 30 years of exceptional expertise in clinical operations spanning APAC, Africa, and LATAM.
José Alberto Peña Gónzalez
Head of Market Access Operations, Mexico
Former VP & GM Mexico Pharmaceuticals at GSK, with over 30 years of expertise in pharmaceutical management and strategy, specializing in the international healthcare industry with a strong emphasis on China and LATAM.
Tapas Majumdar
CFO
Former Finance Director at GSK with over 20 years of distinguished clinical finance expertise across MEA and APAC.
Adeeb Khan
VP Data & Technology
Innovation and Technology leader with over 25 years of global experience at Microsoft, Deloitte, and Vodafone, conceptualising, developing, and maintaining omnichannel, SaaS, marketing, mobile, data, and technology platforms, serving millions of users worldwide for the most respected brands.
Heba Magdy
BD Director
Former Bioinformatician at DKFZ Germany with 10 years of experience in Medical Research. Recognized for spearheading successful initiatives that drive business growth and foster strategic partnerships in several CROs. Committed to achieving tangible results through innovative business development strategies and maintaining high standards of excellence.
Manda Miksa
QA Director
Dedicated QA Director, renowned for developing and maintaining ISO and GxP-compliant quality management systems across various industries, consistently exceeding client and regulatory expectations.
Advisory Board
Dr. Hans Bock MD
Chairman
Former VP and Chief Medical Officer at GSK & Novartis Vaccines, with nearly 40 years of clinical research and development experience in Africa, MENA, APAC, Japan, and Australia.
Jane Wynen
Clinical Operations
Former VP and Head of Global Medical Affairs Operations at Janssen, with over 20 years of experience in medical and clinical operations in vaccines.
Dr. Haiwen Tang MD, PhD
Clinical & Medical Affairs
Former Medical Director at GSK Biologicals, with 25 years of strategic leadership and medical expertise.
Gamal Saleh
Commercial & BD Strategy
Former VP and Global Vaccines Commercial Leader at GSK, with 38 years of experience in pharmaceuticals, consumer health, and vaccines across the globe.
Benoît Grégoire
Biologics DP Manufacturing
Former Manufacturing Director for Emerging Markets at GSK Vaccines, with over 30 years of experience in biologics manufacturing in Emerging Markets, Middle East, and Africa.
Dr. Stephen Cook, PhD
Regulatory Affairs
Former VP of Vaccine Global Regulatory Affairs at GSK, with over 37 years of invaluable experience in global regulatory affairs.
Dr. Youlin Qiao MD, PhD
Oncology Expert
Globally renowned expert in the field of cancer prevention and control. As a Professor in the Department of Global Health at the School of Population Medicine & Public Health, CAMS PUMC, China, he has made significant contributions through his extensive work on the etiology, primary intervention, and early detection of cancer. Recognized for his outstanding achievements, Qiao has received numerous prestigious awards, including the prestigious WHO/IARC Medal of Honor in 2011 for his significant contributions to cancer research and global health.
